HEXCEL CORP /DE/
Business
HEXCEL CORP /DE/ manufactures advanced lightweight composite materials and engineered composite structures for commercial aerospace, space & defense, and industrial customers. Its main products include carbon fiber, fabrics and specialty reinforcements, prepregs, resins and other fiber‑reinforced matrix materials, honeycomb cores, structural adhesives, pultruded profiles, engineered honeycomb parts, RF/EMI and microwave‑absorbing materials, and thermoplastic additive manufacturing parts. The company operates through two reportable segments: Composite Materials and Engineered Products. It serves global markets via manufacturing facilities, sales offices, representatives and select distributors across the Americas, Europe, Asia Pacific, India and Africa.
Summary from filing dated 2025-02-05
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 1,894 | 1,903 | 1,789 | 1,578 | 1,325 | |
| Cost of sales | 1,459 | 1,433 | 1,356 | 1,221 | 1,075 | |
| Gross margin | 435 | 470 | 433 | 357 | 250 | |
| Selling, general and administrative expenses | 169 | 177 | 164 | 148 | 135 | |
| Research and technology expenses | 56 | 57 | 53 | 46 | 45 | |
| Other operating expense (income) | 38 | 50 | 1 | −12 | 18 | |
| Operating income | 172 | 186 | 215 | 175 | 52 | |
| Interest expense, net | 38 | 31 | 34 | 36 | 38 | |
| Other expense (income) | −1 | 0 | 72 | −11 | −9 | |
| Total income before income taxes | 135 | 155 | 110 | 150 | 22 | |
| Income tax expense | 26 | 23 | 12 | 32 | 6 | |
| Income before equity in earnings | 109 | 132 | 98 | 118 | 16 | |
| Equity in earnings from affiliated companies | 0 | 0 | 8 | 8 | 0 | |
| Net income | 109 | 132 | 106 | 126 | 16 | |
| Basic net income per common share: | 1.38 | 1.61 | 1.25 | 1.5 | 0.19 | |
| Diluted net income per common share: | 1.37 | 1.59 | 1.24 | 1.49 | 0.19 | |
| Basic | 80 | 82 | 85 | 84 | 84 | |
| Diluted | 80 | 83 | 86 | 85 | 85 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 71 | 125 | 227 | 112 | 128 | |
| Accounts receivable, net | 249 | 212 | 235 | 223 | 160 | |
| Inventories | 329 | 356 | 334 | 319 | 246 | |
| Contract assets | 36 | 30 | 25 | 32 | 31 | |
| Prepaid expenses and other current assets | 46 | 51 | 43 | 39 | 40 | |
| Assets held for sale | 0 | 8 | 0 | 10 | 13 | |
| Total current assets | 731 | 782 | 864 | 734 | 616 | |
| Property, plant and equipment | 3,322 | 3,163 | 3,196 | 3,088 | 3,110 | |
| Less accumulated depreciation | −1,711 | −1,566 | −1,517 | −1,430 | −1,364 | |
| Property, plant and equipment, net | 1,612 | 1,597 | 1,679 | 1,658 | 1,746 | |
| Goodwill and other intangible assets | 240 | 237 | 251 | 256 | 268 | |
| Investments in affiliated companies | 5 | 5 | 5 | 48 | 45 | |
| Other assets | 117 | 105 | 119 | 142 | 145 | |
| Total assets | 2,704 | 2,726 | 2,919 | 2,837 | 2,819 | |
| Short-term borrowings | 0 | 100,000 | 100,000 | 200,000 | 900,000 | |
| Accounts payable | 147 | 142 | 159 | 156 | 113 | |
| Accrued compensation and benefits | 79 | 100 | 76 | 70 | 54 | |
| Financial instruments | 4 | 8 | 6 | 22 | 6 | |
| Accrued liabilities | 93 | 99 | 75 | 83 | 73 | |
| Liabilities held for sale | 0 | 4 | 0 | — | — | |
| Total current liabilities | 323 | 354 | 316 | 330 | 248 | |
| Long-term debt | 993 | 701 | 699 | 723 | 822 | |
| Retirement obligations | 28 | 32 | 43 | 43 | 53 | |
| Deferred income taxes | 87 | 81 | 111 | 126 | 140 | |
| Other non-current liabilities | 23 | 31 | 34 | 61 | 71 | |
| Total liabilities | 1,453 | 1,198 | 1,202 | 1,283 | 1,334 | |
| Common stock, $0.01 par value, 200.0 shares authorized, 112.1 shares and 111.6 shares issued at December 31, 2025 and 2024, respectively | 1 | 1 | 1 | 1 | 1 | |
| Additional paid-in capital | 995 | 970 | 937 | 905 | 879 | |
| Retained earnings | 2,307 | 2,252 | 2,169 | 2,105 | 2,013 | |
| Accumulated other comprehensive loss | −13 | −115 | −74 | −174 | −127 | |
| Total stockholders' equity including treasury stock value | 3,290 | 3,108 | 3,033 | 2,837 | 2,766 | |
| Less - Treasury stock, at cost, 36.4 shares at December 31, 2025 and 30.6 shares at December 31, 2024 | −2,039 | −1,580 | −1,316 | −1,282 | −1,280 | |
| Total stockholders' equity | 1,251 | 1,528 | 1,717 | 1,554 | 1,486 | |
| Total liabilities and stockholders' equity | 2,704 | 2,726 | 2,919 | 2,837 | 2,819 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income | 109 | 132 | 106 | 126 | 16 | |
| Depreciation and amortization | 122 | 124 | 125 | 126 | 138 | |
| Amortization of deferred financing costs and debt discount | 100,000 | 400,000 | 600,000 | 700,000 | 3 | |
| Deferred income taxes | 6 | −17 | −33 | −3 | −3 | |
| Equity in earnings from affiliated companies | 0 | 0 | −8 | −8 | 0 | |
| Stock-based compensation | 14 | 22 | 21 | 20 | 19 | |
| Debt extinguishment costs | 400,000 | 0 | 0 | — | — | |
| Loss on divestiture of assets | 5 | 0 | 0 | — | — | |
| Restructuring expenses, net of payments | 9 | 0 | −4 | −700,000 | −6 | |
| Pension Settlement | 0 | 0 | 71 | 0 | 0 | |
| Gain on sale of assets | 0 | 0 | −800,000 | −19 | 0 | |
| Impairment of assets | 0 | 29 | 3 | 2 | 0 | |
| Loss (gain) on sale of investments | 0 | 0 | 3 | −300,000 | 0 | |
| Decrease (increase) in accounts receivable | −23 | 11 | −9 | −63 | −41 | |
| Increase in inventories | 45 | −34 | −9 | −82 | −40 | |
| (Increase) decrease in prepaid expenses and other current assets | −4 | −7 | 3 | −8 | 13 | |
| Increase (decrease) in accounts payable/accrued liabilities | −20 | 29 | −12 | 81 | 50 | |
| Other net | −35 | −200,000 | 2 | 3 | 2 | |
| Net cash provided by operating activities | 231 | 290 | 257 | 173 | 152 | |
| Capital expenditures | −73 | −87 | −108 | −76 | −28 | |
| Payments on divestiture of assets | −3 | 0 | 0 | — | — | |
| Proceeds from sale of assets | 0 | 0 | 10 | 21 | 0 | |
| Proceeds from sale of investments | 0 | 0 | 47 | 500,000 | 0 | |
| Net cash used for investing activities | −76 | −87 | −51 | −55 | −28 | |
| Repayment of finance lease obligation and other debt, net | −4 | 300,000 | −200,000 | −600,000 | −900,000 | |
| Issuance costs related to senior credit facility | 0 | 0 | −3 | 0 | 0 | |
| Redemption of 4.7% senior notes due 2025 | −300 | 0 | 0 | — | — | |
| Proceeds from issuance of 5.875% senior notes due 2035 | 300 | 0 | 0 | — | — | |
| Dividends paid | −54 | −49 | −42 | −34 | 0 | |
| Repurchase of stock | −454 | −252 | −30 | 0 | 0 | |
| Activity under stock plans | 5 | −500,000 | 7 | 4 | 7 | |
| Net cash used for financing activities | −212 | −302 | −93 | −130 | −97 | |
| Effect of exchange rate changes on cash and cash equivalents | 3 | −3 | 1 | −4 | −3 | |
| Net (decrease) increase in cash and cash equivalents | −54 | −102 | 115 | −16 | 24 | |
| Interest, net of capitalized interest | 40 | 34 | 35 | 35 | 36 | |
| Income Taxes | 7 | 42 | 59 | 36 | 1 | |
| Accrual basis additions to property, plant and equipment | 81 | 81 | 122 | 70 | 41 |